Intestinal apoM inhibition as a specific approach to reduce plasma chylomicron and triglyceride levels (IMAGE)

Research Foundation for the State University of New York

Intestinal apoM inhibition as a specific approach to reduce plasma chylomicron and triglyceride levels

Caption

Read more about the new world-class SUNY discoveries that are available for licensing at SUNY TechConnect. The Research Foundation offers numerous pathways to translate SUNY innovation into economic development opportunities.

Credit

State University of New York

Usage Restrictions

No restrictions

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.